ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 051,05
0,26%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Aligos Therapeutics Inc (ALGS)

  7. Aligos Therapeutics Inc (ALGS) Actualités

ALGS Aligos Therapeutics Inc

0,7907
-0,0553 (-6,54%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Aligos Therapeutics Inc ALGS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0553 -6,54% 0,7907 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,829 0,7811 0,85 0,8101 0,846
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202422:05GLOBEAligos Therapeutics to Announce 1st Quarter 2024 Financial..
25/4/202422:05GLOBEAligos Therapeutics Presents Positive Clinical Data at..
25/4/202414:00GLOBEAligos Therapeutics Mourns the Passing of MASH Industry..
09/4/202414:00GLOBEAligos Therapeutics to Participate in the Piper Sandler..
03/4/202414:00GLOBEAligos Therapeutics Announces First Subjects Dosed in the..
27/3/202413:00GLOBEAligos Therapeutics Presents Positive Clinical Data at APASL..
18/3/202413:00GLOBEAligos Therapeutics Announces the Initiation of the Phase 2a..
12/3/202421:05GLOBEAligos Therapeutics Reports Recent Business Progress..
05/3/202422:05GLOBEAligos Therapeutics to Announce 4th Quarter 2023 Financial..
04/3/202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202414:00GLOBEAligos Therapeutics To Participate in the Leerink Partners..
20/2/202414:00GLOBEAligos Therapeutics to Host KOL Event to Discuss Phase 2a..
13/2/202414:00GLOBEAligos Therapeutics Strengthens Finance Leadership Team with..
30/1/202413:04EDGAR2Form SC TO-I - Tender offer statement by Issuer
25/1/202412:12EDGAR2Form SC TO-C - Written communication relating to an issuer..
25/1/202412:06EDGAR2Form 8-K - Current report
28/11/202322:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22/11/202322:05EDGAR2Form 8-K - Current report
17/11/202322:38EDGAR2Form S-3 - Registration statement under Securities Act of..
15/11/202322:01EDGAR2Form 8-K - Current report
07/11/202318:03EDGAR2Form D - Notice of Exempt Offering of Securities
02/11/202321:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/11/202321:05EDGAR2Form 8-K - Current report
25/10/202323:05EDGAR2Form 8-K - Current report
18/10/202314:45EDGAR2Form 8-K - Current report
12/9/202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202322:01EDGAR2Form 8-K - Current report
03/8/202322:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:05EDGAR2Form 8-K - Current report
01/8/202322:52EDGAR2Form 8-K - Current report
25/7/202322:02EDGAR2Form 8-K - Current report
21/7/202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
ALGS
Aligos Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés